skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system

Authors:
; ; ; ; ; ; ; ; ORCiD logo
Publication Date:
Research Org.:
Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23); National Institutes of Health (NIH)
OSTI Identifier:
1361453
Alternate Identifier(s):
OSTI ID: 1395310; OSTI ID: 1515333
Report Number(s):
LLNL-JRNL-737725
Journal ID: ISSN 1932-6203; 10.1371/journal.pone.0177761
Grant/Contract Number:  
AC52-07NA27344
Resource Type:
Published Article
Journal Name:
PLoS ONE
Additional Journal Information:
Journal Name: PLoS ONE Journal Volume: 12 Journal Issue: 6; Journal ID: ISSN 1932-6203
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES; Insects; Cell membranes; Dimers (Chemical physics); Enzyme-linked immunoassays; Immunoblotting; Immunostaining; Phosphorylation; Tyrosine kinases

Citation Formats

Scharadin, Tiffany M., He, Wei, Yiannakou, Yianni, Tomilov, Alexey A., Saldana, Matthew, Cortopassi, Gino A., Carraway, Kermit L., Coleman, Matthew A., and Henderson, Paul T. Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system. United States: N. p., 2017. Web. doi:10.1371/journal.pone.0177761.
Scharadin, Tiffany M., He, Wei, Yiannakou, Yianni, Tomilov, Alexey A., Saldana, Matthew, Cortopassi, Gino A., Carraway, Kermit L., Coleman, Matthew A., & Henderson, Paul T. Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system. United States. doi:10.1371/journal.pone.0177761.
Scharadin, Tiffany M., He, Wei, Yiannakou, Yianni, Tomilov, Alexey A., Saldana, Matthew, Cortopassi, Gino A., Carraway, Kermit L., Coleman, Matthew A., and Henderson, Paul T. Tue . "Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system". United States. doi:10.1371/journal.pone.0177761.
@article{osti_1361453,
title = {Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system},
author = {Scharadin, Tiffany M. and He, Wei and Yiannakou, Yianni and Tomilov, Alexey A. and Saldana, Matthew and Cortopassi, Gino A. and Carraway, Kermit L. and Coleman, Matthew A. and Henderson, Paul T.},
abstractNote = {},
doi = {10.1371/journal.pone.0177761},
journal = {PLoS ONE},
number = 6,
volume = 12,
place = {United States},
year = {2017},
month = {6}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1371/journal.pone.0177761

Save / Share:

Works referenced in this record:

Update on HER1–3 in Advanced Non–Small-Cell Lung Cancer
journal, December 2012


Advances in the use of nanoscale bilayers to study membrane protein structure and function
journal, January 2014


Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III
journal, July 2010


Epidermal growth factor receptor mutations in lung cancer
journal, March 2007

  • Sharma, Sreenath V.; Bell, Daphne W.; Settleman, Jeffrey
  • Nature Reviews Cancer, Vol. 7, Issue 3
  • DOI: 10.1038/nrc2088

The deaf and the dumb: the biology of ErbB-2 and ErbB-3
journal, March 2003


EGFR Signaling and Drug Discovery
journal, January 2009


Molecular pathology of lung cancer: key to personalized medicine
journal, January 2012


Different Apolipoproteins Impact Nanolipoprotein Particle Formation
journal, November 2007

  • Chromy, Brett A.; Arroyo, Erin; Blanchette, Craig D.
  • Journal of the American Chemical Society, Vol. 129, Issue 46, p. 14348-14354
  • DOI: 10.1021/ja074753y

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
journal, February 2005

  • Kobayashi, Susumu; Boggon, Titus J.; Dayaram, Tajhal
  • New England Journal of Medicine, Vol. 352, Issue 8
  • DOI: 10.1056/NEJMoa044238

An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
journal, September 2003


The Membrane Mimetic Affects the Spatial Structure and Mobility of EGFR Transmembrane and Juxtamembrane Domains
journal, October 2015


Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
journal, May 1989


Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
journal, February 2005


Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles
journal, June 2009

  • Baker, Sarah E.; Hopkins, Robert C.; Blanchette, Craig D.
  • Journal of the American Chemical Society, Vol. 131, Issue 22
  • DOI: 10.1021/ja809251f

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
journal, January 2007

  • Sergina, Natalia V.; Rausch, Megan; Wang, Donghui
  • Nature, Vol. 445, Issue 7126
  • DOI: 10.1038/nature05474

Epidermal Growth Factor Receptor (EGFR) Antibody Down-regulates Mutant Receptors and Inhibits Tumors Expressing EGFR Mutations
journal, November 2006

  • Perez-Torres, Marianela; Guix, Marta; Gonzalez, Adriana
  • Journal of Biological Chemistry, Vol. 281, Issue 52
  • DOI: 10.1074/jbc.M607958200

Applications of Phospholipid Bilayer Nanodiscs in the Study of Membranes and Membrane Proteins
journal, February 2007

  • Nath, Abhinav; Atkins, William M.; Sligar, Stephen G.
  • Biochemistry, Vol. 46, Issue 8
  • DOI: 10.1021/bi602371n

A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
journal, July 1994


Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment
journal, June 2009


A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment
journal, November 2011

  • Zhang, Hongzheng; Yun, Sujin; Batuwangala, Thil D.
  • International Journal of Cancer, Vol. 131, Issue 4
  • DOI: 10.1002/ijc.26427

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M Mutation
journal, December 2010


Characterization and Purification of Polydisperse Reconstituted Lipoproteins and Nanolipoprotein Particles
journal, July 2009

  • Blanchette, Craig; Segelke, Brent; Fischer, Nicholas
  • International Journal of Molecular Sciences, Vol. 10, Issue 7
  • DOI: 10.3390/ijms10072958

The Biology of Epidermal Growth Factor Receptor in Lung Cancer
journal, June 2004


Mechanisms of tumor resistance to EGFR-targeted therapies
journal, March 2009

  • Hopper-Borge, Elizabeth A.; Nasto, Rochelle E.; Ratushny, Vladimir
  • Expert Opinion on Therapeutic Targets, Vol. 13, Issue 3
  • DOI: 10.1517/14712590902735795

The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
journal, June 2009


Specificity within the EGF family/ErbB receptor family signaling network
journal, January 1998


Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
journal, August 2014


Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer Interface
journal, August 2005


The Juxtamembrane Region of EGFR Takes Center Stage
journal, June 2009


Kinetics of binding, endocytosis, and recycling of EGF receptor mutants
journal, April 1992


Cell-free expression of functional receptor tyrosine kinases
journal, August 2015

  • He, Wei; Scharadin, Tiffany M.; Saldana, Matthew
  • Scientific Reports, Vol. 5, Issue 1
  • DOI: 10.1038/srep12896

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
journal, July 2003

  • Holbro, T.; Beerli, R. R.; Maurer, F.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 15
  • DOI: 10.1073/pnas.1537685100

Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
journal, May 2006

  • Nahta, Rita; Yu, Dihua; Hung, Mien-Chie
  • Nature Clinical Practice Oncology, Vol. 3, Issue 5
  • DOI: 10.1038/ncponc0509

The Crystal Structure of a Truncated ErbB2 Ectodomain Reveals an Active Conformation, Poised to Interact with Other ErbB Receptors
journal, February 2003


Functional and Structural Stability of the Epidermal Growth Factor Receptor in Detergent Micelles and Phospholipid Nanodiscs
journal, September 2008

  • Mi, Li-Zhi; Grey, Michael J.; Nishida, Noritaka
  • Biochemistry, Vol. 47, Issue 39
  • DOI: 10.1021/bi801006s

Ligand-induced ErbB receptor dimerization
journal, February 2009


Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
journal, April 2004


Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
journal, February 2010


Targeting HER proteins in cancer therapy and the role of the non-target HER3
journal, July 2007


ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer
journal, May 2008


Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth
journal, November 2006


Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
journal, February 2003

  • Cho, Hyun-Soo; Mason, Karen; Ramyar, Kasra X.
  • Nature, Vol. 421, Issue 6924
  • DOI: 10.1038/nature01392

Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR Inhibitors
journal, January 2005

  • Varkondi, Edit; SchÄFer, Eszter; BÖKÖNyi, GyÖRgyi
  • Journal of Receptors and Signal Transduction, Vol. 25, Issue 1
  • DOI: 10.1081/RRS-200055095

Trastuzumab and Antiestrogen Therapy: Focus on Mechanisms of Action and Resistance
journal, January 2006


Effect of Membrane Fluidity on Tyrosine Kinase Activity of Reconstituted Epidermal Growth Factor Receptor
journal, March 2001

  • Ge, Gaoxiang; Wu, Jing; Lin, Qishui
  • Biochemical and Biophysical Research Communications, Vol. 282, Issue 2
  • DOI: 10.1006/bbrc.2001.4600

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer
journal, February 2010

  • Khambata-Ford, Shirin; Harbison, Christopher T.; Hart, Lowell L.
  • Journal of Clinical Oncology, Vol. 28, Issue 6
  • DOI: 10.1200/JCO.2009.25.2890

Improved yields of the extracellular domain of the epidermal growth factor receptor produced using the baculovirus expression system by medium replacement following infection
journal, December 1995

  • Tom, R. L.; Debanne, M. T.; B�dard, C.
  • Applied Microbiology and Biotechnology, Vol. 44, Issue 1-2
  • DOI: 10.1007/BF00164480

Regulation of human EGF receptor by lipids
journal, May 2011

  • Coskun, U.; Grzybek, M.; Drechsel, D.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 22
  • DOI: 10.1073/pnas.1105666108

The Cell-Free Integration of a Polytopic Mitochondrial Membrane Protein into Liposomes Occurs Cotranslationally and in a Lipid-Dependent Manner
journal, September 2012


Untangling the ErbB signalling network
journal, February 2001

  • Yarden, Yosef; Sliwkowski, Mark X.
  • Nature Reviews Molecular Cell Biology, Vol. 2, Issue 2
  • DOI: 10.1038/35052073

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene
journal, January 1987


    Works referencing / citing this record: